YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis.
暂无分享,去创建一个
T. Tsuda | Y. Sakaguchi | K. Yamanishi | K. Iwatsuki | N. Nakagawa | S. Futatsugi-Yumikura | Y. Imai | S. Aochi | Yasutomo Imai
[1] A. Ishida-Yamamoto,et al. Serum cytokines and growth factor levels in Japanese patients with psoriasis , 2009, Clinical and experimental dermatology.
[2] R. Flavell,et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis , 2009, The Journal of experimental medicine.
[3] Ying Sun,et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. , 2008, The New England journal of medicine.
[4] J. Dziura,et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. , 2007, The New England journal of medicine.
[5] H. Vestergaard,et al. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance , 2006, Inflammation Research.
[6] K. Eberhardt,et al. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis , 2000, Scandinavian journal of rheumatology.